The shares of Red Hat, Inc. (NYSE:RHT) started off the last trading session with the price of $153.52 while closing the day with the price of $155.08. The shares of Red Hat, Inc. (NYSE:RHT) Fell -0.26% with the Gain of 1.56 points.
The shares of Red Hat, Inc. (NYSE:RHT) traded with the day volume of 1.35 Million shares whereas its average trading volume is 1.8 Million.
While analyzing the past performance of the stock we can see that the shares of Red Hat, Inc. (NYSE:RHT) Gain 3.5% in the last week while rising 24.41% in the last month. Past quarter performance shows the green light with 25.27%. The semi-annual and annual performance shows 44.77% and 88.64% respectively.
Some critical values of the shares of Red Hat, Inc. (NYSE:RHT) to be discussed here are: the beta which shows the value at 1.09 while Average True Range of Red Hat, Inc. (NYSE:RHT) demonstrate the value at 4.05. The weekly and monthly volatility of the shares of Red Hat, Inc. (NYSE:RHT) are indicated at 2.95% and 2.86%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 78.71.
While studying the financial position of the shares of Red Hat, Inc. (NYSE:RHT), we can see that the Market capitalization of the company is at 27.46 Billion. The shares outstanding for the company is 177.06 Million and the shares float stands at 176.12 Million. The income of the company stand at 337.2 Million while the sales stand at 2.78 Billion.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 1.84, Price to Earnings or P/E is at 84.33, Price to Sales P/S show the value of 9.89, the Return on Asset ROA stood at 0.073 and the Return on Equity ROE depicted at 0.25 while Return on Investment ROI is at 0.133.
Conatus Pharmaceuticals Inc. (NASDAQ:CNAT)
Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) started its previous trading session at $7.27 and closed at $7.24 showing a Fell of -0.41 Percent.
The Company traded with an average Volume of 557.21 Million whereas, its Day Volume stood at 850072.
Looking at the performance of the stock, Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) Gain 7.26% in the last week in its shares price and 42.8% in the last month. Quarterly performance shows a green of 80.55 Percent while Semi-Annual and Annual performances shows a 20.27 and 53.72 percent respectively.
Beta for Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) stands at 1.32 while the ATR (average true range) is at 0.51. The Stock’s Weekly and Monthly Volatility is 10.55% and 7.94% respectively showing a RSI value of 74.51.
While studying the financial position of the shares of Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), we can see that the Market capitalization of the company is at 224.08 Million. The shares outstanding for the company is 30.95 Million and the shares float stands at 28.97 Million.
The Company generated an income of -17400000 and the sales of 35.4 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.61 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 6.33 respectively.
The Return on Assets stands at -0.197, ROE shows a value of -0.616 and ROI for Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) is -0.426 as of Trailing Twelve Months period.
